CRL vs MAIA · rev $2.00B vs $56.9M cap
Charles River Laboratories (CRL) versus MAIA Biotechnology Inc. (MAIA) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
MAIA Biotechnology Inc. (MAIA) is a biotechnology company listed on US.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported MAIA revenue for 2024-12-31 was $0. Net income was -$23.3M. MAIA currently screens at market cap $56.9M.
CRL currently screens at market cap $7.78B. MAIA currently screens at market cap $56.9M.
Not investment advice. Open the CRL and MAIA stock pages for the full models.
Not investment advice.